Home/Filings/4/0000874716-23-000120
4//SEC Filing

Britt Irene Chang 4

Accession 0000874716-23-000120

CIK 0000874716other

Filed

Sep 5, 8:00 PM ET

Accepted

Sep 6, 5:00 PM ET

Size

8.0 KB

Accession

0000874716-23-000120

Insider Transaction Report

Form 4
Period: 2023-09-01
Transactions
  • Award

    Restricted Stock Unit

    2023-09-01+208208 total
    Common Stock (208 underlying)
  • Award

    Non-Qualified Stock Option (right-to-buy)

    2023-09-01+493493 total
    Exercise: $511.29Exp: 2033-08-31Common Stock (493 underlying)
Footnotes (3)
  • [F1]This equity grant represents pro rata equity compensation earned by the reporting person as a non-employee Director from her election to the IDEXX Laboratories, Inc. Board of Directors on July 11, 2023 until the 2024 annual meeting of stockholders.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. Restricted stock units vest in one installment on the date of the 2024 annual meeting of stockholders or May 17, 2024, whichever event occurs earlier.
  • [F3]Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vests in one installment on May 17, 2024 or on the date of the 2024 annual meeting of stockholders, whichever event is earlier.

Issuer

IDEXX LABORATORIES INC /DE

CIK 0000874716

Entity typeother

Related Parties

1
  • filerCIK 0001502314

Filing Metadata

Form type
4
Filed
Sep 5, 8:00 PM ET
Accepted
Sep 6, 5:00 PM ET
Size
8.0 KB